Erisyon Logo Black

Charting the new era of


erisyon moonlit
Erisyon Inc. is commercializing the world’s first single-molecule protein sequencer that promises to transform the way we detect, treat, and track disease.

Inheriting over a decade of work performed at the University of Texas at Austin’ s Center for Systems and Synthetic Biology, Erisyon was founded in March 2018 by a group of technologists and entrepreneurs with the ambition to usher in new discoveries that make the world healthier, safer, and more abundant.

Our Team

  • Talli Somekh
    Talli Somekh


  • Jag Swaminathan PhD
    Jag Swaminathan PhD


  • Angela Bardo PhD
    Angela Bardo PhD

    VP of Product

  • Prof Eric Anslyn
    Prof Eric Anslyn

    UT Austin

  • Prof Edward MArcotte
    Prof Edward MArcotte

    UT Austin